https://news.medxy.ai/acog-2026-cervical-cancer-guidelines/Medxy AIen2026-04-26T09:00:07-07:00ACOG Endorses Updated 2026 Cervical Cancer Screening Guidelines: Key Changes and Implications https://news.medxy.ai/zh/glp-1-sglt-2-combo-therapy/Medxy AIzh2026-04-25T22:22:39-07:00GLP-1受体激动剂与SGLT-2抑制剂联合治疗可降低MASLD和2型糖尿病患者的肝脏和心血管风险 https://news.medxy.ai/ja/glp-1-sglt-2-combination-therapy/Medxy AIja2026-04-25T22:21:17-07:00GLP-1受容体作動薬とSGLT-2阻害薬の併用療法は、MASLDおよび2型糖尿病患者の肝臓および心血管リスクを低下させる https://news.medxy.ai/vi/glp-1-sglt-2-therapy/Medxy AIvi2026-04-25T22:19:46-07:00Liệu pháp kết hợp giữa các chất kích thích thụ thể GLP-1 và các chất ức chế SGLT-2 giảm nguy cơ gan và tim mạch ở bệnh MASLD và tiểu đường tuýp 2 https://news.medxy.ai/glp1-sglt2-combination-therapy/Medxy AIen2026-04-25T22:17:15-07:00Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors Reduces Liver and Cardiovascular Risks in MASLD and Type 2 Diabetes https://news.medxy.ai/zh/cd16-%ce%b3d-t-cells-hbv/Medxy AIzh2026-04-25T21:33:52-07:00CD16+ γδ T 细胞：通过抗体依赖性细胞毒作用控制 HBV 病毒的新角色 https://news.medxy.ai/ja/cd16-gamma-d-t-cells-hbv-control/Medxy AIja2026-04-25T21:33:11-07:00CD16+ γδ T細胞：抗体依存性細胞障害を介したHBVウイルス制御の新たなプレーヤー https://news.medxy.ai/vi/cd16-gamma-t-cells-hbv/Medxy AIvi2026-04-25T21:31:59-07:00Tế bào CD16+ γδ T: Một yếu tố mới trong kiểm soát vi-rút HBV thông qua độc tính tế bào phụ thuộc kháng thể https://news.medxy.ai/cd16-gamma-d-t-cells-hbv-control/Medxy AIen2026-04-25T21:27:28-07:00CD16+ γδ T Cells: A Novel Player in HBV Viral Control Through Antibody-Dependent Cytotoxicity https://news.medxy.ai/zh/clonal-lymphocyte-expansion/Medxy AIzh2026-04-25T20:10:58-07:00克隆淋巴细胞扩增和JAK-STAT突变驱动难治性乳糜泻 https://news.medxy.ai/ja/clonal-lymphocyte-proliferation-celiac-disease/Medxy AIja2026-04-25T20:09:43-07:00クローン性リンパ球の増殖とJAK-STAT変異が難治性セリアック病を駆動 https://news.medxy.ai/vi/clonal-expansion-celiac-disease/Medxy AIvi2026-04-25T20:08:01-07:00Sự Mở Rộng Clonal của Bạch Huyết Bào và Biến Đổi JAK-STAT Kích Thúc Bệnh Celiac Kháng Trị https://news.medxy.ai/clonal-lymphocyte-expansions/Medxy AIen2026-04-25T20:03:55-07:00Clonal Lymphocyte Expansions and JAK-STAT Mutations Drive Refractory Celiac Disease https://news.medxy.ai/zh/evt-superior-efficacy/Medxy AIzh2026-04-25T19:52:13-07:00EVT在前脑动脉闭塞性卒中显示优越疗效：来自ORIENTAL-MeVO注册研究的见解 https://news.medxy.ai/ja/evt-fronto-cerebral-stroke/Medxy AIja2026-04-25T19:51:43-07:00EVTは前頭葉大脳動脈閉塞脳卒中で優れた結果を示す：ORIENTAL-MeVOレジストリからの洞察 https://news.medxy.ai/vi/evt-results-stroke-oriental-mevo/Medxy AIvi2026-04-25T19:51:08-07:00EVT Hiển Thị Kết Quả Tốt Hơn Trong Đột Quỵ Hẹp Mạch Động Mạch Não Trước: Những Nhận Định từ Đăng Ký ORIENTAL-MeVO https://news.medxy.ai/evt-superior-outcomes-stroke/Medxy AIen2026-04-25T19:48:57-07:00EVT Shows Superior Outcomes in Anterior Cerebral Artery Occlusion Stroke: Insights from the ORIENTAL-MeVO Registry https://news.medxy.ai/zh/best-sleep-duration-epilepsy-risk/Medxy AIzh2026-04-25T18:55:55-07:00最佳睡眠时长可减轻局灶性癫痫的认知衰退和痴呆风险：来自英国生物银行研究的见解 https://news.medxy.ai/ja/optimal-sleep-duration-epilepsy-risk/Medxy AIja2026-04-25T18:54:47-07:00最適な睡眠時間は局灶性てんかんにおける認知機能低下と認知症リスクを軽減：UK Biobank研究からの洞察 https://news.medxy.ai/vi/optimal-sleep-time-epilepsy/Medxy AIvi2026-04-25T18:53:26-07:00Thời gian ngủ tối ưu giảm thiểu suy giảm nhận thức và nguy cơ mất trí trong động kinh cục bộ: Những hiểu biết từ nghiên cứu UK Biobank https://news.medxy.ai/optimal-sleep-cognitive-health/Medxy AIen2026-04-25T18:49:52-07:00Optimal Sleep Duration Mitigates Cognitive Decline and Dementia Risk in Focal Epilepsy: Insights from the UK Biobank Study https://news.medxy.ai/zh/ugmi-hba1c-replacement/Medxy AIzh2026-04-24T19:56:07-07:00uGMI：糖尿病管理中更准确的HbA1c替代指标 https://news.medxy.ai/ja/ugmi-hba1c-diabetes-management/Medxy AIja2026-04-24T19:55:24-07:00uGMI: HbA1cの糖尿病管理におけるより正確な代替指標 https://news.medxy.ai/vi/ugmi-vs-hba1c-diabetes-management/Medxy AIvi2026-04-24T19:54:18-07:00uGMI: Một lựa chọn chính xác hơn so với HbA1c cho việc quản lý đái tháo đường https://news.medxy.ai/ugmi-alternative-hba1c/Medxy AIen2026-04-24T19:52:11-07:00uGMI: A More Accurate Alternative to HbA1c for Diabetes Management https://news.medxy.ai/zh/personalized-thyroid-cancer-treatment/Medxy AIzh2026-04-24T19:38:07-07:00推进甲状腺乳头状癌个性化治疗：预测隐匿性淋巴结转移的机器学习模型 https://news.medxy.ai/ja/thyroid-cancer-treatment-advancements/Medxy AIja2026-04-24T19:37:11-07:00甲状腺乳头状癌の個別化治療の進展：隠匿性リンパ節転移を予測する機械学習モデル https://news.medxy.ai/vi/thyroid-cancer-treatment-prediction/Medxy AIvi2026-04-24T19:35:44-07:00Tiến bộ trong điều trị cá nhân hóa ung thư tuyến giáp dạng nhú: Mô hình học máy để dự đoán di căn hạch bạch huyết ẩn https://news.medxy.ai/personalized-papillary-thyroid-cancer/Medxy AIen2026-04-24T19:33:14-07:00Advancing Personalized Treatment in Papillary Thyroid Cancer: A Machine-Learning Model for Predicting Occult Lymph Node Metastasis https://news.medxy.ai/zh/long-term-air-pollution-metabolic-syndrome/Medxy AIzh2026-04-24T18:19:00-07:00长期空气污染与代谢综合征老年人不良身体成分变化相关 https://news.medxy.ai/ja/long-term-air-pollution-metabolic-syndrome-elderly/Medxy AIja2026-04-24T18:17:55-07:00長期大気汚染が代謝症候群を有する高齢者の体組成変化と関連 https://news.medxy.ai/vi/long-term-air-pollution-effects-elderly/Medxy AIvi2026-04-24T18:16:07-07:00Ô nhiễm không khí dài hạn liên quan đến sự thay đổi cơ thể bất lợi ở người cao tuổi mắc hội chứng chuyển hóa https://news.medxy.ai/air-pollution-body-composition/Medxy AIen2026-04-24T18:12:41-07:00Long-term Air Pollution Linked to Adverse Body Composition Changes in Older Adults with Metabolic Syndrome https://news.medxy.ai/zh/sacubitril-valsartan-blood-pressure/Medxy AIzh2026-04-24T16:57:20-07:00沙库必曲/缬沙坦对血压影响中的缓激肽作用被揭示 https://news.medxy.ai/ja/bradykinin-role-in-blood-pressure/Medxy AIja2026-04-24T16:56:32-07:00サクビトリル/バルサルタンの血圧効果におけるブラジキニンの控えめな役割が明らかに https://news.medxy.ai/vi/bradykinin-sacubitril-valsartan/Medxy AIvi2026-04-24T16:55:33-07:00Vai trò khiêm tốn của Bradykinin trong tác động huyết áp của Sacubitril/Valsartan được tiết lộ https://news.medxy.ai/bradykinin-role-sacubitril-valsartan/Medxy AIen2026-04-24T16:53:19-07:00Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed